Details for New Drug Application (NDA): 214957
✉ Email this page to a colleague
The generic ingredient in GABAPENTIN is gabapentin. There are twenty-nine drug master file entries for this compound. Seventy-eight suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 214957
Tradename: | GABAPENTIN |
Applicant: | Ascent Pharms Inc |
Ingredient: | gabapentin |
Patents: | 0 |
Pharmacology for NDA: 214957
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 214957
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GABAPENTIN | gabapentin | TABLET;ORAL | 214957 | ANDA | Camber Pharmaceuticals, Inc. | 31722-166 | 31722-166-01 | 100 TABLET in 1 BOTTLE (31722-166-01) |
GABAPENTIN | gabapentin | TABLET;ORAL | 214957 | ANDA | Camber Pharmaceuticals, Inc. | 31722-166 | 31722-166-05 | 500 TABLET in 1 BOTTLE (31722-166-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Oct 1, 2021 | TE: | AB1 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 800MG | ||||
Approval Date: | Oct 1, 2021 | TE: | AB1 | RLD: | No |
Complete Access Available with Subscription